Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATRA and Eltrombopag for Steroid-Resistant/Relapsed ITP
NCT05438875Phase 3Completed
- Sponsor
- Peking University People's Hospital
- Start
- Oct 2022
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tretinoin in immune thrombocytopenia (ITP), sponsored by Peking University People's Hospital. Started Oct 2022; status: completed.
02
Drugs
tretinoin
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT05438875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05438875.